Altogether, the examples reported highlight that even with typical clinico-pathological features (including BCOR immunohistochemistry) or a DNA-methylation score suggestive of HGNET-BCOR or sarcoma with BCOR alteration, the confirmation of BCOR-ITD by an appropriate technique is mandatory. The gene discussed is BCOR; the disease is sarcoma.